BIOAVAILABILITY OF QUINIDINE IN CONGESTIVE HEART-FAILURE

被引：15

作者：

UEDA, CT

DZINDZIO, BS

机构：

[1] UNIV NEBRASKA,MED CTR,DIV CARDIOVASC DIS,OMAHA,NE 68105

[2] UNIV NEBRASKA,MED CTR,CTR CARDIOVASC,OMAHA,NE 68105

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 11卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1981.tb01173.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：571 / 577

页数：7

共 29 条

[1] C14-LABELED HYDROCHLOROTHIAZIDE IN HUMAN BEINGS [J].

ANDERSON, KV ;

BRETTELL, HR ;

AIKAWA, JK .

ARCHIVES OF INTERNAL MEDICINE, 1961, 107 (05) :736-&

[2] PHARMACOKINETICS OF HYDROCHLOROTHIAZIDE IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].

BEERMANN, B ;

GROSCHINSKYGRIND, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (06) :579-583

[3] RELATION BETWEEN SERUM QUINIDINE LEVELS AND RENAL FUNCTION - STUDIES IN NORMAL SUBJECTS AND PATIENTS WITH CONGESTIVE FAILURE AND RENAL INSUFFICIENCY [J].

BELLET, S ;

ROMAN, LR ;

BOZA, A .

AMERICAN JOURNAL OF CARDIOLOGY, 1971, 27 (04) :368-&

[4]

BENET LZ, 1976, EFFECT DISEASE STATE, P33

[5] PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE [J].

BENOWITZ, NL ;

MEISTER, W .

CLINICAL PHARMACOKINETICS, 1976, 1 (06) :389-405

[6] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[7]

BOYES RN, 1970, J PHARMACOL EXP THER, V174, P1

[8]

CONRAD KA, 1977, CIRCULATION, V55, P1

[9] EFFECT OF CONGESTIVE HEART-FAILURE ON QUINIDINE PHARMACOKINETICS [J].

CROUTHAMEL, WG .

AMERICAN HEART JOURNAL, 1975, 90 (03) :335-339

[10]

CROUTHAMEL WG, 1974, NEW ENGL J MED, V290, P1379

← 1 2 3 →